ALS Worldwide welcomes any questions or comments you might have.  We provide free, personalized and confidential support services to anyone in the ALS community—whether you are a patient or a loved one, friend, health care professional or caregiver of someone diagnosed.

Get help now! Fill out the Online Profile Form or if you would prefer to talk with someone by email or phone first, please contact us at [email protected] or 1-414-831-6879.

For all other inquiries, please use the email form to the right and we will respond promptly to your request.Thank you.

ALS Worldwide
1800 North Prospect Avenue, Suite 4B
Milwaukee, WI 53202

ALS Worldwide
Sorted by: July 2017 | View All
July 28, 2017

Time to be Hopeful

While tremendous work remains to be done to address the unmet medical needs of the estimated half a million ALS patients worldwide, there is more hope for the future than ever before. 

July 27, 2017

15-year ALS patient practices mindfulness, meditation with great success!

Begin meditating after just five minutes with the help of Dr. Richard Davidson's free online course, LIFE REIMAGINED.

July 27, 2017

Have you talked with your children about ALS?

Talking about ALS can be difficult with anyone, but extra care should be taken when discussing it with children. 

July 20, 2017

How to Qualify for Social Security Benefits With ALS

Did you know that an ALS diagnosis automatically qualifies for Social Security disability benefits? If you or a loved one has been diagnosed with ALS, you might be eligible for financial resources.

July 11, 2017

This New Study May Unlock The Door To ALS Treatment! Read More, It’s Brilliant.

"Researchers have shown a drug engineered to combat the gene causing spinocerebellar ataxia type 2 (SCA2) might also be used to treat ALS. 

July 10, 2017

More results are in! Edavone shown to provide greater benefits to ALS patients after one year

Data from the open-label extension trial of Edaravone (Radicava) in patients with ALS demonstrated the drug continued to provide benefits after 48 weeks of treatment.